AURA BIOSCIENCES INC's ticker is and the CUSIP is 05153U107. A total of 44 filers reported holding AURA BIOSCIENCES INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $122,970 | -24.7% | 13,709 | +3.7% | 0.00% | 0.0% |
| Q2 2023 | $163,279 | +54.1% | 13,221 | +15.8% | 0.00% | 0.0% |
| Q1 2023 | $105,940 | +16.4% | 11,416 | +31.7% | 0.00% | 0.0% |
| Q4 2022 | $91,014 | -42.4% | 8,668 | -0.4% | 0.00% | 0.0% |
| Q3 2022 | $158,000 | +29.5% | 8,700 | +1.4% | 0.00% | 0.0% |
| Q2 2022 | $122,000 | +100.0% | 8,577 | +208.3% | 0.00% | – |
| Q1 2022 | $61,000 | +24.5% | 2,782 | -4.0% | 0.00% | – |
| Q4 2021 | $49,000 | – | 2,897 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd | 3,039,892 | $27,267,831 | 8.71% |
| Decheng Capital Management III (Cayman), LLC | 1,163,123 | $18,243,928 | 6.09% |
| Regency Capital Management Inc.\DE | 526,978 | $4,726,993 | 4.02% |
| Matrix Capital Management Company, LP | 5,362,870 | $48,104,944 | 0.58% |
| Nantahala Capital Management | 743,892 | $6,672,711 | 0.57% |
| Eventide Asset Management | 3,024,905 | $27,133,398 | 0.49% |
| Rock Springs Capital Management LP | 722,896 | $6,484,377 | 0.17% |
| LEVIN CAPITAL STRATEGIES, L.P. | 81,095 | $727,422 | 0.09% |
| Long Focus Capital Management, LLC | 195,175 | $1,750,720 | 0.06% |
| Values First Advisors, Inc. | 10,401 | $93,299 | 0.06% |